US PATENT SUBCLASS 424 / 184.1
ANTIGEN, EPITOPE, OR OTHER IMMUNOSPECIFIC IMMUNOEFFECTOR (E.G., IMMUNOSPECIFIC VACCINE, IMMUNOSPECIFIC STIMULATOR OF CELL-MEDIATED IMMUNITY, IMMUNOSPECIFIC TOLEROGEN, IMMUNOSPECIFIC IMMUNOSUPPRESSOR, ETC.)

Current as of: June, 1999
Click HD for Main Headings
Click for All Classes

Internet Version by PATENTEC © 1999      Terms of Use


424 /   HD   DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS

184.1ANTIGEN, EPITOPE, OR OTHER IMMUNOSPECIFIC IMMUNOEFFECTOR (E.G., IMMUNOSPECIFIC VACCINE, IMMUNOSPECIFIC STIMULATOR OF CELL-MEDIATED IMMUNITY, IMMUNOSPECIFIC TOLEROGEN, IMMUNOSPECIFIC IMMUNOSUPPRESSOR, ETC.) {15}
185.1  DF  .~> Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same {3}
192.1  DF  .~> Fusion protein or fusion polypeptide (i.e., expression product of gene fusion)
193.1  DF  .~> Conjugate or complex {4}
198.1  DF  .~> Hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, neurotransmitter, or fragment thereof
199.1  DF  .~> Recombinant virus encoding one or more heterologous proteins or fragments thereof
200.1  DF  .~> Recombinant or stably-transformed bacterium encoding one or more heterologous proteins or fragments thereof
201.1  DF  .~> Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.)
202.1  DF  .~> Combination of antigens from multiple viral species (e.g., multivalent viral vaccine, etc.)
203.1  DF  .~> Combination of antigens from multiple bacterial species (e.g., multivalent bacterial vaccine, etc.)
204.1  DF  .~> Virus or component thereof {13}
234.1  DF  .~> Bacterium or component thereof or substance produced by said bacterium (e.g., Legionella, Borrelia, Anaplasma, Shigella, etc.) {23}
265.1  DF  .~> Parasitic organism or component thereof or substance produced by said parasitic organism (e.g., Schistosoma, Dirofilaria, Trichinella, Fasciola, Ancylostoma, Ascaris, etc.) {2}
274.1  DF  .~> Fungus, except allergen, or component thereof or substance produced by said fungus (e.g., Trichophyton, etc.)
275.1  DF  .~> Allergen or component thereof (e.g., ragweed pollen, etc.) {1}
277.1  DF  .~> Cancer cell or component thereof

DEFINITION

Classification: 424/184.1

ANTIGEN, EPITOPE, OR OTHER IMMUNOSPECIFIC IMMUNOEFFECTOR (E.G., IMMUNOSPECIFIC VACCINE, IMMUNOSPECIFIC STIMULATOR OF CELL-DIATED IMMUNITY, IMMUNOSPECIFIC TOLEROGEN, IMMUNOSPECIFIC IMMUNOSUPPRESSOR, ETC.):

(under the class definition) Subject matter involving an antigen, an epitope, or another immunospecific immunoeffector, such as an immunospecific vaccine, an immunospecific stimulator of cell-mediated immunity, an immunospecific tolerogen, or an immunospecific immunosuppressor.

(1) Note. An antigen is a substance that elicits the production of antibodies, wherein the antibodies then have binding specificity for that antigen.

(2) Note. An epitope is a portion of an antigen to which an antibody binds. An epitope is also called an antigenic determinant.

(3) Note. An immunospecific immunoeffector, for the purposes of this subclass and indented subclasses, is a substance that induces a specific immunological effect (e.g., specific immunity to polio), whether it be immunospecific

immunity, immunospecific tolerance, or immunospecific immunosuppression.

(4) Note. This subclass and indented subclasses provide for bioaffecting and body-treating compositions of antigens, epitopes, and other immunospecific immunoeffectors.

(5) Note. This subclass and indented subclasses also provide for bioaffecting and body-treating methods of using antigens, epitopes, and other immunospecific immunoeffectors and compositions thereof.

(6) Note. This and the indented subclasses provide for methods of immunizing to produce protective immunity in vivo (i.e., for vaccination purposes). SEE OR SEARCH THIS CLASS, SUBCLASS:

93.1+, for a nonimmunologic bioaffecting or body-treating composition containing a whole live micro-organism, cell, or virus.

130.1+, for methods of immunizing with an antigen to produce antibodies for recovery, which antibodies are characterized as being useful as bioaffecting or body-treating agents (e.g., to provide passive immunity).

538+, for bee or other insect or arachnid venom for which there is no specific disclosure that it functions as an antigen.

542, for snake venom for which there is no specific disclosure that it functions as an antigen.

SEE OR SEARCH CLASS

435, Chemistry: Molecular Biology and Microbiology,

5+, for antigens involved in in vitro immunoassays involving an enzyme or a micro-organism.

436, Chemistry: Analytical and Immunological Testing,

500+, for antigens involved in in vitro immunoassays not involving an enzyme or a micro-organism.